|
|
Post by charlespk on Mar 16, 2017 15:15:45 GMT -5
MannKind Corporation Reports 2016 Fourth Quarter and Full Year Financial Results
Conference Call to Begin Today at 5:00 PM ET
VALENCIA, Calif., March 16, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today reported financial results for the fourth quarter and full year ended December 31, 2016. Key results include:
Total revenue for the quarter of $12.4 million, including $10.2 million from insulin sales to Sanofi, and net income for the fourth quarter of $54.0 million including $72.0 million from the extinguishment of debt owed to Sanofi
Total revenue for 2016 of $174.8 million, including $172.0 million in revenue previously deferred from the collaboration with Sanofi, and net income for 2016 of $125.7 million, compared with a net loss of $368.4 million for 2015
Finished 2016 with $22.9 million of cash and cash equivalents, not including $30.6 million subsequently received from Sanofi and $16.7 million subsequently received from sale of surplus building
you can read it all at the mannkind website
|
|
|
|
Post by silentknight on Mar 16, 2017 15:23:46 GMT -5
MannKind Corporation Reports 2016 Fourth Quarter and Full Year Financial Results Conference Call to Begin Today at 5:00 PM ET VALENCIA, Calif., March 16, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today reported financial results for the fourth quarter and full year ended December 31, 2016. Key results include: Total revenue for the quarter of $12.4 million, including $10.2 million from insulin sales to Sanofi, and net income for the fourth quarter of $54.0 million including $72.0 million from the extinguishment of debt owed to Sanofi Total revenue for 2016 of $174.8 million, including $172.0 million in revenue previously deferred from the collaboration with Sanofi, and net income for 2016 of $125.7 million, compared with a net loss of $368.4 million for 2015 Finished 2016 with $22.9 million of cash and cash equivalents, not including $30.6 million subsequently received from Sanofi and $16.7 million subsequently received from sale of surplus building you can read it all at the mannkind website So aside from the insulin put that Sanofi paid in full last quarter, they had revenue of $2.2 million. The RLS milestone of $1 million was included, so that leaves them with $1.2 million for the quarter. Their cash burn totaled ~$24 million for the quarter. $1.2 million in true sales revenue with $24 million spent. Ugly. |
|
|
|
Post by mnholdem on Mar 16, 2017 15:31:34 GMT -5
|
|
|
|
Post by rockstarrick on Mar 16, 2017 17:48:35 GMT -5
So how does a man find this shout box 📦 |
|
|
|
Post by esstan2001 on Mar 16, 2017 19:24:45 GMT -5
So how does a man find this shout box 📦 listen carefully in the direction where all the yelling is coming from! Go to | | \ / \/ bottom of post listings .next time  |
|
|
|
Post by mnholdem on Mar 16, 2017 20:12:56 GMT -5
The ProBoards staff will typically open a Shout Box (aka chat room) about 15 minutes before the scheduled start of a webcast and shut it down a few minutes after. I think you have to open one of the forums, like All About MannKind before the Shout Box will open at the bottom of the page. I'm pretty sure you won't see it on the home page. You have to open a forum.
|
|
|
|
Post by liane on Mar 16, 2017 20:14:16 GMT -5
Actually, you can see it at the bottom of the home page.
|
|
|
|
Post by mnholdem on Mar 16, 2017 20:44:17 GMT -5
You heard what the boss said. ;-)
|
|
|
|
Post by rockstarrick on Mar 17, 2017 7:18:53 GMT -5
You heard what the boss said. ;-) Thanks to all for the help, unfortunately I decided to take a nap rather than listen to the ER so I missed the shout box. I find napping during CC's work better for me. Glad to hear the call was good for some and just not bad for others. Good Luck Everybody |
|
